GlaxoSmithKline (GSK)

44.38 +0.10  +0.23%  May 29, 5:19PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

GlaxoSmithKline Historical Price Data

Start Date:
End Date: Pro Data Export
Date Open High Low Close Volume
May 25, 2012 44.20 44.46 44.15 44.28 2242085
May 24, 2012 44.44 44.48 44.00 44.24 2107321
May 23, 2012 44.07 44.12 43.55 43.90 2084956
May 22, 2012 44.50 44.70 44.26 44.43 1864570
May 21, 2012 44.39 44.50 44.31 44.48 1853933
May 18, 2012 44.62 44.62 44.10 44.18 2658220
May 17, 2012 44.89 45.00 44.33 44.35 2447635
May 16, 2012 45.33 45.50 45.24 45.37 1903156
May 15, 2012 45.58 45.71 45.27 45.47 2333801
May 14, 2012 45.58 45.95 45.47 45.59 2368960
May 11, 2012 45.40 45.98 45.40 45.62 1370218
May 10, 2012 45.78 45.78 45.42 45.50 1176172
May 9, 2012 45.23 45.74 45.13 45.50 2422602
May 8, 2012 46.63 46.65 46.05 46.57 2105081
May 7, 2012 46.03 46.78 45.85 46.57 2049737
May 4, 2012 46.68 46.74 46.08 46.08 2332446
May 3, 2012 46.75 46.94 46.58 46.90 2107658
May 2, 2012 46.31 46.75 46.22 46.67 1984321
May 1, 2012 46.71 46.75 46.57 46.58 1312680
April 30, 2012 46.53 46.61 46.14 46.23 1693812
April 27, 2012 46.44 46.59 46.17 46.51 2437402
April 26, 2012 45.70 46.31 45.67 46.20 2348727
April 25, 2012 45.84 46.00 45.67 46.00 4865208
April 24, 2012 47.09 47.39 47.03 47.21 1959595
April 23, 2012 47.01 47.24 46.68 47.19 2148757
April 20, 2012 47.26 47.48 47.12 47.29 3143366
April 19, 2012 46.87 46.94 46.48 46.69 3153241
April 18, 2012 46.20 46.48 46.12 46.37 2122966
April 17, 2012 45.67 46.00 45.43 45.93 1687304
April 16, 2012 45.48 45.66 45.28 45.58 2130095
April 13, 2012 44.72 44.80 44.47 44.59 2836047
April 12, 2012 45.07 45.48 45.01 45.47 1647323
April 11, 2012 44.86 45.20 44.85 44.97 3466940
April 10, 2012 45.37 45.51 44.76 45.04 4408959
April 9, 2012 44.69 45.28 44.58 45.02 1723833
April 5, 2012 44.75 45.08 44.75 45.02 1681228
April 4, 2012 45.46 45.52 44.98 45.32 2980284
April 3, 2012 45.99 46.00 45.50 45.72 1738277
April 2, 2012 45.20 45.96 45.17 45.84 2908035
March 30, 2012 45.03 45.10 44.73 44.91 1678038
March 29, 2012 44.70 44.98 44.53 44.96 2685095
March 28, 2012 45.77 45.80 45.15 45.43 1847497
March 27, 2012 45.66 45.73 45.49 45.64 1960547
March 26, 2012 45.26 45.65 45.23 45.61 1926146
March 23, 2012 44.99 45.20 44.77 45.12 2270891
March 22, 2012 45.21 45.41 45.16 45.28 1428268
March 21, 2012 45.44 45.63 45.28 45.40 1545766
March 20, 2012 45.34 45.68 45.29 45.51 1171731
March 19, 2012 45.32 45.62 45.28 45.49 1629252
March 16, 2012 45.28 45.35 45.05 45.18 1798584
  1. First
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  10. Last
Get Historical Data
Display in Live Stream: Done
Options

GSK News

@mydanilo It had nothing to do with those news. That was already priced in. Seems like Patent news regarding $TEVA and $GSK was the trigger.
about 6 hours ago by mitrado
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 8 hours ago by abubnic
Auxilium Pharma Sues Watson
May 29, 12:45PM
Teva Issues 2012 Outlook
May 29, 11:00AM
4 Stocks Buffett May Be Buying in Europe
May 25, 12:21PM Investor Place
Finding a Pathway to Approval
May 24, 2:53PM Fool
$GSK reacts to $HGSI poison pill. Stubborn, or what? It seems they do not want to get pushed or pulled.
about 7 days ago by OysterX
20 Giants for a 6% Dividend Yield
May 21, 9:07AM Fool
@xjun "totally betrayed" $AMRN says: "Sorry, it's not personal. Look at some of my neighbours: $ONTY, $SPPI, $NVAX, $GSK, $TEVA, $CELG ..."
about 12 days ago by mitrado
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
Still think that $GSK will not succeed with $HGSI takeover at 13/share. They will increase the offer price, but probably not above 15.
about 13 days ago by OysterX
News related to $GSK, currently 0.0% since open: 'Prestige Brands posts small fiscal 4Q loss' http://stks.co/3s9V
about 13 days ago by TradeBot
Gilead Sciences’ HIV Drugs Clear a Hurdle
May 17, 10:00AM Investor Place
$GSK Trametinib also in the spotlight at ASCO '12 with six presentations over 4 days. http://stks.co/3roL
about 13 days ago by abubnic
$GSK Dabrafenib getting its share of attention at ASCO '12 with 50 presentations over 4 days. http://stks.co/3roI
about 13 days ago by abubnic
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 14 days ago by laughing_stock
Don't see $XNPT popping 100% like $ARNA did, not as glamorous and still has to settle with $GSK. They would get 10 million if still partnrd
about 14 days ago by Glopolon
5 Dividends to Reinvest
May 14, 10:34AM Fool
$ARNA -Big brand name companies may be interested in buyout $GSK $PFE $SNY $ABT First weight-loss drug in US may be approved in June $SPY $$
about 16 days ago by peterumble
$XNPT, No Debt, Drug has already been approved for RLS, so safety issues known. Court case with $GSK still out there, want settlement.
about 18 days ago by Glopolon
Some really tempting European stocks that pay healthy dividends $SNY $HBC $SI $ABB $SNY $GSK $RDS.B all above 4%
about 20 days ago by sld1986
$VVUS Racked With Losses, Vivus is Putting All Its Eggs in This Basket http://stks.co/3kNz $OREX $ARNA $PFE $LLY $GSK
about 20 days ago by DrNick
RT @JasonMilano8 $AMRN Here is a news about current CEO of Amarin selling his former company Reliant to ($GSK) in 2007: http://stks.co/3k0G
about 21 days ago by JasonMilano8
Breakfast Links | via @PointsnFigures http://stks.co/3jto $AMZN $GSK $HGSI $ZNGA
about 21 days ago by STNet
That's a surprise. $GSK goes hostile with $HGSI offer at 13. Did not expect that and am curious whether HGSI has something up its sleeve.
about 21 days ago by OysterX
$AMRN Here is a news about current CEO of Amarin selling his former company Reliant to GlaxoSmithKline ($GSK) in 2007: http://stks.co/3jYt
about 21 days ago by JasonMilano8
$XNPT, Only non-dopaminergic option for RLS, is the advantage over generics. If $XNPT can work things out with $GSK, this should be $5+
about 21 days ago by Glopolon
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 22 days ago by abubnic
@BioRunUp @GantosJ $XNPT, Hope that they can settle w/ $GSK, and if Astellas in Japan is competent, then $XNPT is looking good.
about 22 days ago by Glopolon
$XNPT Sounds like Astellas is going to be better partner than $GSK, Hope they can work things out with $GSK re: Horizant.
about 23 days ago by Glopolon
$XNPT $GSK, FDA PDUFA date June 9th for Horizant treating postherpetic neuralgia. Horizant already approved in Japan for restless leg synd.
about 26 days ago by Glopolon
Best Yielding Large Cap Healthcare Stocks + http://stks.co/3cMJ + $JNJ $PFE $NVS $MRK $GSK $SNY $NVO $UNH $BMY $TEVA $MDT $BAX $AGN $SYK
about 28 days ago by DividendYield

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 44.38 +0.10 +0.23% 111.75B
GSIT 4.18 -0.02 -0.48% 120.25M
GSIG 11.98 +0.13 +1.10% 397.09M
GSI 0.9874 +0.12 +13.48%
GSH 16.41 +0.11 +0.67% 2.314B
GSB 2.06 -0.09 -4.19% 39.15M
GSAT 0.391 -0.01 -3.43% 120.61M
GS 97.82 +1.12 +1.16% 47.86B
GRZ 3.40 +0.11 +3.34% 195.89M
GRX 8.14 +0.04 +0.49%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close